Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer.

Autor: Diven MA; New York Presbyterian-Brooklyn Methodist Hospital, Brooklyn, New York.; New York Presbyterian Weill Cornell Medical Center, New York, New York., Tshering L; New York Presbyterian Weill Cornell Medical Center, New York, New York., Ma X; Department of Population Health Sciences, Division of Biostatistics, Weill Cornell Medicine, New York, New York., Hu JC; New York Presbyterian Weill Cornell Medical Center, New York, New York., Barbieri C; Department of Urology, Weill Cornell Medicine, New York, New York., McClure T; Department of Urology, Weill Cornell Medicine, New York, New York., Nagar H; Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2429760. Date of Electronic Publication: 2024 Aug 01.

A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).

Autor: Wolfe S; Department of Radiation Oncology, Weill Cornell Medicine/NewYork-Presbyterian, 525 East 68th Street, N-046, Box 169, New York, NY, 10065, USA., Diven MA; Department of Radiation Oncology, Brooklyn Methodist Hospital/New York-Presbyterian, Brooklyn, NY, USA., Marciscano AE; Department of Radiation Oncology, Weill Cornell Medicine/NewYork-Presbyterian, 525 East 68th Street, N-046, Box 169, New York, NY, 10065, USA., Zhou XK; Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine/NewYork-Presbyterian, New York, NY, USA., Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Steinberg ML; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Miccio JA; Penn State Cancer Institute, Hershey, PA, USA., Camilleri P; GenesisCare, Oxford, UK., Nagar H; Department of Radiation Oncology, Weill Cornell Medicine/NewYork-Presbyterian, 525 East 68th Street, N-046, Box 169, New York, NY, 10065, USA. hnagar@med.cornell.edu.

Publikováno v: BMC cancer [BMC Cancer] 2023 Sep 30; Vol. 23 (1), pp. 923. Date of Electronic Publication: 2023 Sep 30.

Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning.

Autor: Nelson MH; Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425 USA., Bowers JS; Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425 USA., Bailey SR; Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425 USA., Diven MA; Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425 USA., Fugle CW; Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425 USA., Kaiser AD; Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892 USA., Wrzesinski C; Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892 USA., Liu B; Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425 USA., Restifo NP; Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892 USA., Paulos CM; Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425 USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2016 Feb 16; Vol. 4, pp. 6. Date of Electronic Publication: 2016 Feb 16 (Print Publication: 2016).

Harnessing the Microbiome to Enhance Cancer Immunotherapy.

Autor: Nelson MH; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA ; Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA., Diven MA; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA., Huff LW; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA ; Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA., Paulos CM; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA ; Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.

Publikováno v: Journal of immunology research [J Immunol Res] 2015; Vol. 2015, pp. 368736. Date of Electronic Publication: 2015 May 25.

Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment.

Autor: Gupta, Kajal H., Giurini, Eileena F., Zloza, Andrew

Publikováno v: Frontiers in Oncology; 2024, p1-8, 8p